Business
Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology
Patent covers advanced signal processing for middle ear sensors, further advancing the Company's position in leveraging the ear for fully implanted hearing devicesWhite Bear Lake, Minnesota--(Newsfile Corp. - September 19, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that it has received an Issue Notification from the European Patent Office and has been granted European.
About this update from Envoy Medical, Inc.
[{"type":"text","content":"Patent covers advanced signal processing for middle ear sensors, further advancing the Company's position in leveraging the ear for fully implanted hearing devices","length":167,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"White Bear Lake, Minnesota--(Newsfile Corp. - September 19, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that it has received an Issue Notification from the European Patent Office and has been granted European Patent No. 4338791 which became effective September 17, 2025. The newly issued European patent strengthens Envoy Medical's global patent portfolio following recent issuances in the United States, Australia, and Hong Kong.","length":572,"tagName":"p"},{"type":"text","content":"The title of the patent is "Implantable Cochlear System with Integrated Components and Lead Characterization" and relates to sophisticated systems and methods for compensating for variability in a middle ear sensor. Specifically, it covers the use of analog and digital signals from a middle ear sensor representing received stimulus signals. The digital filter can be adjusted to normalize the frequency response of the digitally filtered signals with respect to the stimulus signals.","length":495,"tagName":"p"},{"type":"text","content":""This latest patent reflects our continued innovation in fully implanted hearing technology that is designed to work with the body's natural anatomy. We believe these additional patents strengthen our position and continue to create shareholder value by expanding our global patent portfolio. We are not only protecting our groundbreaking innovations but also supporting our mission to deliver life-changing, fully implantable solutions to the people around the world who experience disabling hearing loss," said Brent Lucas, CEO of Envoy Medical.","length":561,"tagName":"p"},{"type":"text","content":"Envoy Medical's fully implanted cochlear implant technology, including the investigational Acclaim® Cochlear Implant, is designed to eliminate the need for external microphones and wearable hardware, instead utilizing a sensor designed to leverage the natural ear. The company believes this techno...